Echo Street Capital Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Echo Street Capital Management’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-4,257	Closed	-$1.23M	–	611
2022 Q4	$1.23M	Buy	+4,257	New	+$1.3M	0.01%	133
2022 Q1	–	Sell	-4,187	Closed	-$919K	–	755
2021 Q4	$919K	Sell	4,187 -3,169	-43%	-$616K	0.01%	273
2021 Q3	$1.33M	Buy	7,356 +5,129	+230%	+$1M	0.01%	195
2021 Q2	$449K	Buy	2,227 +471	+27%	+$98.5K	﹤0.01%	400
2021 Q1	$377K	Buy	1,756 +827	+89%	+$182K	﹤0.01%	375
2020 Q4	$220K	Buy	+929	New	+$213K	﹤0.01%	347

Other funds holding VRTX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Echo Street Capital Management's VRTX Position: Q1 2023 in Review

Echo Street Capital Management sold out of Vertex Pharmaceuticals (VRTX) in Q1 2023, closing a stake of 4,257 shares — an estimated $1.23M sold.

Echo Street Capital Management first reported a position in VRTX in Q4 2020 and held it in 6 quarters. The position peaked at $1.33M in Q3 2021. 1,207 funds tracked by Wall St. Rank hold VRTX as of Q1 2023.

Echo Street Capital Management reported no remaining Vertex Pharmaceuticals position as of Q1 2023 after selling out during the quarter.
Echo Street Capital Management sold 4,257 Vertex Pharmaceuticals shares in Q1 2023, an estimated $1.23M.
Echo Street Capital Management first reported a position in Vertex Pharmaceuticals in Q4 2020 and held it in 6 quarters.
Echo Street Capital Management's Vertex Pharmaceuticals position peaked at $1.33M in Q3 2021.
1,207 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2023.

Based on Echo Street Capital Management's 13F filing for Q1 2023, filed 15 May 2023.